© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
November 21, 2022
Demand for treatment of anxiety and depression remained high for the third consecutive year as the demand for the treatment of trauma- and stressor-related and substance use disorders has increased.
November 15, 2022
Anxiety disorders include generalized anxiety, social anxiety, panic disorder, and fear of certain places or situations, including crowds and public transportation.
October 25, 2022
People with anxiety and related disorders were found to have vaccine hesitancy related to concerns regarding adverse effects and efficacy.
October 10, 2022
New research finds that mental health has replaced COVID-19 as the top health concern among Americans, but deeper analysis needs to be done into whether depression and anxiety are truly becoming more widespread.
October 03, 2022
Teva Pharmaceutical Industries announced that fremanezumab can successfully reduce 2 common migraine comorbid symptoms—anxiety and depression.
September 23, 2022
Specialty pharmacies need processes, systems and tools to quickly determine medication delivery status, reassure confidence, and alleviate patient anxiety.
September 22, 2022
Research suggests that acupuncture may be able to clinically reduce symptoms of anxiety in this patient population.
September 02, 2022
Addiction to checking the news can worsen mental and physical illness, and in many cases may require individuals to reduce, or even stop, consuming any news.
August 29, 2022
Pregnant women with epilepsy showed more symptoms of anxiety and depression than healthy pregnant or non-pregnant women, but mental health screening may help.
August 03, 2022
As leaders, we should ask ourselves if any of our people might feel imposter syndrome and what can we do to calm their anxiety and boost their confidence.